• 4523 Citations
  • 35 h-Index
20012018
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 12 Similar Profiles
Urinary Bladder Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Cystectomy Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2012 2018

Urinary Bladder Neoplasms
Drug Therapy
African Americans
Breast Neoplasms
Urinary Bladder
Phase III Clinical Trials
docetaxel
Paclitaxel
Randomized Controlled Trials
Neoplasms

Research Output 2001 2018

Modelling cost-effectiveness of a biomarker-based approach to neoadjuvant chemotherapy for muscle-invasive bladder cancer

Lotan, Y., Woldu, S. L., Sanli, O., Black, P. & Milowsky, M. I. Jan 1 2018 (Accepted/In press) In : BJU international.

Research output: Contribution to journalArticle

Urinary Bladder Neoplasms
Cost-Benefit Analysis
Biomarkers
Drug Therapy
Muscles

Optimizing anticancer therapy in metastatic non-castrate prostate cancer: American society of clinical oncology clinical practice guideline

Morris, M. J., Bryan Rumble, R., Basch, E., Hotte, S. J., Loblaw, A., Rathkopf, D., Celano, P., Bangs, R. & Milowsky, M. I. May 20 2018 In : Journal of Clinical Oncology. 36, 15, p. 1521-1539 19 p.

Research output: Contribution to journalArticle

Medical Oncology
docetaxel
Practice Guidelines
Androgens
Prostatic Neoplasms
7 Citations
Renal Cell Carcinoma
Vascular Endothelial Growth Factor A
Neoplasms
Angiogenesis Inhibitors
Neoplasm Metastasis
3 Citations

A systematic review of strategies to prevent cisplatin-induced nephrotoxicity

Crona, D. J., Faso, A., Nishijima, T. F., McGraw, K. A., Galsky, M. D. & Milowsky, M. I. May 1 2017 In : Oncologist. 22, 5, p. 609-619 11 p.

Research output: Contribution to journalReview article

1 Citations

Checkpoint inhibition: a new beginning for urothelial cancer

Rose, T. L. & Milowsky, M. I. Feb 1 2017 In : The Lancet Oncology. 18, 2, p. 160-161 2 p.

Research output: Contribution to journalComment/debate

Neoplasms